HAVN Life Sciences Inc. (HAVLF) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Port Moody, BC, Canada. The current CEO is Tim Moore.
HAVLF has IPO date of 2021-01-08, 6 full-time employees, listed on the Other OTC, a market capitalization of $2.57K.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
